“Partnering with Genesis Therapeutics presents a unique opportunity to leverage their AI technologies to accelerate the ...

Incyte and Genesis Therapeutics have agreed to discover and optimize at least two initial small molecule compounds through Genesis’s AI platform, Genesis Exploration of Molecular Space (GEMS).

Every time you get sick, your body keeps a record of it. It does so through your immune system, a vast army of cells that mobilizes to fight off diseases. And after the infection is over — if it’s ...

NVIDIA (NASDAQ: NVDA) has introduced Evo 2, an advanced artificial intelligence (AI) system aimed at transforming the field ...

As of Feb. 10, Johns Hopkins University in Baltimore has taken the most NIH funding so far in the current fiscal year ending ...

Dr. Mehmet Oz, nominated to run the Centers for Medicare & Medicaid Services, will sell shares in Eli Lilly and UnitedHealth.

Google has unveiled an AI co-scientist built on its Gemini 2.0 platform, aiming to accelerate scientific research by ...

NVIDIA BioNeMo can be used in biomolecular research applications such as predicting the form and function of proteins with ...

Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...

Fox Chase Cancer Center’s Cancer Epigenetics Institute will hold its fifth annual free hybrid Cancer Epigenetics Symposium at ...